Mtt Assay

The measured signal reflects two related properties: how many cells remain and how metabolically active those cells are. Consequently, stronger absorbance generally indicates greater overall viable-cell activity under the tested condition, but it should not be interpreted as a direct measure of cell number alone. This distinction matters when comparing treatments that alter cellular activity.

Formazan formation provides the assay’s measurable color change. After active cells reduce the yellow MTT compound, the purple product is insoluble, so it must be solubilized before absorbance can be recorded. The microplate reader then converts the color intensity into a quantitative signal for comparing cellular responses across tested conditions.

Signal magnitude depends on the combined contribution of viable-cell abundance and metabolic activity under each experimental condition. Treatments may therefore produce a lower reading by reducing the number of viable cells, reducing their activity, or both. Interpreting the result requires relating absorbance to the specific treatment and biological question, rather than viewing color intensity in isolation.

The core workflow follows three linked stages: expose cells to the experimental conditions, allow metabolically active cells to reduce MTT to purple formazan, and solubilize that insoluble product before measuring absorbance with a microplate reader. Keeping these stages conceptually separate helps connect the treatment, the cellular response, and the final colorimetric readout.

It is useful when researchers need a screening readout for treatment-related changes in cell viability, metabolic activity, or proliferation. Common applications include cytotoxicity testing, drug-response evaluation, growth-pattern analysis, and assessment of cellular effects caused by experimental treatments. These uses span cell biology, pharmacology, and biomedical research.

Absorbance measurements allow researchers to compare the overall viable-cell signal produced under different tested conditions. Such comparisons can indicate whether a treatment is associated with reduced or increased cellular responses relative to another condition, supporting early evaluation of cytotoxicity, drug response, or growth. Interpretation remains tied to both cell number and metabolic activity.